Earnings Call Summary | CTS Corp(CTS.US) Q2 2024 Earnings Conference
Earnings Call Summary | CTS Corp(CTS.US) Q2 2024 Earnings Conference
Adjusted diluted earnings per share for Q2 were $0.54, down 10% year-over-year but up 14% sequentially.The following is a summary of the CTS Corporation (CTS) Q2 2024 Earnings Call Transcript:
以下是CTS公司（CTS）Q2 2024業績會議電話記錄的摘要：
Financial Performance:
金融業績：
CTS reported Q2 2024 revenue of $130 million, a decrease of 10% from the previous year. Non-transportation sales increased by 4% year-over-year.
Adjusted gross margin improved by 80 basis points year-over-year to 35.8%.
Adjusted diluted earnings per share for Q2 were $0.54, down 10% year-over-year but up 14% sequentially.
CTS報告2024財年第二季度營業收入爲1.3億美元，同比下降10％。非運輸銷售同比增長4％。
調整後毛利率同比提高80個點子至35.8％。
2024財年第二季度調整後稀釋每股收益爲0.54美元，同比下降10％，環比增長14％。
Business Progress:
業務進展：
CTS completed the acquisition of SyQwest, enhancing its defense market segment and expecting it to be accretive in 2025.
Notable sales growth in defense and medical segments and key wins across various markets including medical therapeutics and industrial printing.
Introduced important innovations like eBrake and advanced sensors, improving product range and competitive positioning.
CTS完成了收購SyQwest，增強了其國防市場業務，預計2025年將產生增益。
在國防和醫療領域的顯着銷售增長以及在醫療治療和工業印刷等各個市場的關鍵勝利。
引入重要創新，如eBrake和先進傳感器，改善產品範圍和競爭定位。
Opportunities:
機會：
Diversification in non-transportation markets like industrial, medical, and aerospace and defense which showed strong sales and bookings increment.
Megatrends such as automation, connectivity, energy efficiency, and minimally invasive medical procedures expected to drive future growth.
非運輸市場的多樣化，如工業、醫療和航空航天與國防，在銷售和預訂上均表現強勁。
自動化、連接性、能效和微創醫療程序等重大趨勢預計將推動未來增長。
Risks:
風險：
Transportation end market showed continued weakness, with a 22% year-over-year sales decline and soft demand expected through 2024.
Commercial vehicle market and China market challenges persist, impacting sales and competitive dynamics.
運輸終端市場持續疲軟，同比下降22％，預計需求疲軟至2024年。
商用車市場和中國市場的挑戰仍然存在，影響銷售和競爭格局。
More details: CTS Corp IR
更多詳情：CTS Corp IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
